Systemic thrombolysis with newer thrombolytics vs anticoagulation in acute intermediate risk pulmonary embolism: a systematic review and meta-analysis.

Mathew, Don; Seelam, Susmitha; Bumrah, Karandeep; Sherif, Akil; Shrestha, Utsav

Mathew, Don; Seelam, Susmitha; Bumrah, Karandeep; Sherif, Akil; Shrestha, Utsav.

Afiliación

Mathew D; Department of Internal Medicine, University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA, USA. mathewd@upmc.edu.
Seelam S; Department of Internal Medicine, University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA, USA.
Bumrah K; Department of Internal Medicine, University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA, USA.
Sherif A; Department of Cardiology, St Vincent Hospital, Worcester, MA, USA.
Shrestha U; Department of Pulmonary and Critical Care Medicine, West Virginia University, Morgantown, WV, USA.

BMC Cardiovasc Disord ; 23(1): 482, 2023 09 29.

Article en En | MEDLINE | ID: mdl-37770910

Asunto(s)

Fibrinolíticos; Embolia Pulmonar; Humanos; Fibrinolíticos/efectos adversos; Anticoagulantes/efectos adversos; Terapia Trombolítica/efectos adversos; Terapia Trombolítica/métodos; Embolia Pulmonar/etiología; Hemorragia/inducido químicamente; Hemorragias Intracraneales/inducido químicamente; Enfermedad Aguda; Resultado del Tratamiento

Palabras clave

Anticoagulation; Intermediate risk PE; Meta-analysis; Systemic thrombolysis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Embolia Pulmonar / Fibrinolíticos Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: BMC Cardiovasc Disord Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google